GUILIN SANJIN PHARGUILIN SANJIN PHARGUILIN SANJIN PHAR

GUILIN SANJIN PHAR

No trades
See on Supercharts

002275 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research and production of traditional Chinese and Natural medicine. It specializes in traditional Chinese medicine, western medicine, raw materials and extraction. The company's products include Sanjin Watermelon Frost series for throat, oral cavity, and tooth diseases; Sanjin tablets for bladder inflammation, kidney inflammation, urinary tract inflammation, and prostate inflammation; Yuye granules for cold, cough, laryngitis, dry mouth, sore throat, reddish, and scanty urine; Vertigo-calming tablet for treatment of vertigo caused by the trouble of liver and kidney; Naomaitai capsule used in ischemic stroke (cerebral block); Compound Salvia Prionitis Hance tablet clear heat and eliminate toxicity; Notoginseng Capsule used to treat all kinds of hemorrhagic diseases; Shuanghu Zhongtong capsule used for injuries from fall, sprain, and rheumatoid joint pain; Gecko Dingchuan capsule used for cough caused by consumptive deficiency, chest distress, shortness of breath, spontaneous perspiration, and night sweat; and Tianqi Weitong Jiaonang used to treat Hyperacidity, belching and sour regurgitation, stomachache, passing tarry stools, chronic gastritis, gastric ulcer, and duodenal bulbar ulcer. Guilin Sanjin Pharmaceutical was founded in 1967 and is headquartered in Guilin, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

002275 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company